INSIGHTS ON LIQUID DOSE MANUFACTURING
-
A Simple Method For Cell Growth Media Preparation
Explore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.
-
Ensure Sterility In Small-Batch Drug Production
Automation and sterility are critical for small-batch drug manufacturing. Learn how robotic isolators streamline vial filling, reduce contamination risk, and support advanced therapies with precision.
-
Why Lower Endotoxin Levels Matter: Raising The Bar For Patient Safety And Product Quality
Strengthen patient safety and regulatory compliance with comprehensive endotoxin control strategies designed to support the evolving demands of injectable and advanced pharmaceutical products.
-
Rethinking Fill-Finish To Reduce API Loss In Early Development
Early-stage drug programs can preserve constrained API supplies by replacing large-scale manufacturing defaults with deliberate, right-sized fill-finish designs that minimize avoidable process waste.
-
Protecting Your Drug Product: Integrating Engineering And Quality8/31/2026
Engineering decisions in fill/finish directly shape product quality and sterility assurance. This article examines how inert gas purging, plunger placement, dosing verification, and barrier systems interact across line design.
-
Spray Dried Biologics For Nasal Dosage Forms5/5/2026
A fireside chat explores spray drying for nasal biologics, covering formulation science, particle design, delivery advantages, and testing strategies to move from concept to clinic.
-
Three Key Actions To Minimize Dead Volumes10/10/2025
Minimizing liquid dead volume helps labs conserve costly reagents and scarce samples while boosting assay throughput. Learn how advanced liquid level detection technologies are driving efficiency.
-
Innovation In Filtration3/18/2025
Filtration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. Explore how its simplicity and reliability make it indispensable.
-
Maintaining Cell Viability During The Cryovial Filling Process4/21/2025
Maintaining cell viability during cryovial filling is a critical challenge in cell therapy manufacturing. This presentation introduces cryoFIL®, a cutting-edge automated cryovial filling platform designed to deliver high-precision, aseptic, and scalable solutions for cryovial filling.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Streamline diagnostic manufacturing from initial laboratory testing through high-volume commercial production. Modular assembly platforms offer precise liquid dosing to ensure regulatory compliance.
-
Modular aseptic isolation combines sterility assurance, rapid bio-decontamination, glove and chamber leak testing, and validation-ready controls to support safer pharmaceutical and biotech production.
-
Aseptic fill‑finish services support parenteral drug products with advanced formulation development, scalable vial and prefilled syringe manufacturing, and integrated quality and regulatory support.
-
Dec’s ability to provide end-to-end solutions from API manufacturing to primary packaging filling covers the complete range from R&D processes and small batches to large filling campaigns. Our solutions include state of the art robotics for the filling and handling of complex delivery systems like pre-filled syringes (PFS).
-
Medicines are highly sensitive to primary packaging components, which can affect compatibility with container closure systems. Discover Alba® syringes, designed for sensitive biologics, including highly concentrated drugs vulnerable to silicone interaction and ophthalmic medications.